Last close ₹1,463.80down ₹67.10 (4.38%)BSE ₹1,464.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,530.90.
52-week range of traded prices to 23 Oct 2026
₹1,299.40Low, 2 Apr 2026₹1,952.50High, 6 Aug 2026
- Next results date: the board meets on 28 Oct 2026 to consider: financial results and fund raising.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,25,522 Cr70th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 21.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Apr 2026
- 4.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 21.3%
- NIMNet interest margin. Net interest income ÷ the average assets that earn interest × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 6.79%
- Cost of fundsCost of funds. Interest paid ÷ the average of what the company pays interest on × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 7.43%
- Credit costCredit cost. What was set aside for loans that may not be repaid ÷ average loans given × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 1.77%
- ROAReturn on assets. Profit after tax ÷ average total assets × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. It equals net interest income + other income − operating expenses − provisions + exceptional items − tax + the lines below tax, each on the same base. For the year to Mar 2026.
- 2.34%
- LeverageAssets per rupee of net worth. Average total assets ÷ average net worth: rupees of assets for each rupee of net worth; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 8.26times net worth
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 32,39,30756.0% delivered
Cholamandalam Investment and Finance Company board meetings
163 filed, newest first. Page 2 of 4.
Nov 2019
5 Nov · Board meeting
Oct 2019
Jul 2019
30 Jul · Board meeting
Apr 2019
30 Apr · Board meeting
Jan 2019
Oct 2018
30 Oct · Board meeting
3 Oct · Board meeting
Not held on this date
Jul 2018
26 Jul · Board meeting
May 2018
31 May · Board meeting
Apr 2018
23 Apr · Board meeting
Jan 2018
30 Jan · Board meeting
Dec 2017
Oct 2017
31 Oct · Board meeting
Jul 2017
27 Jul · Board meeting
May 2017
3 May · Board meeting
Apr 2017
Jan 2017
Oct 2016
Jul 2016
Apr 2016
29 Apr · Board meeting
Mar 2016
Jan 2016
29 Jan · Board meeting
Dec 2015
23 Dec · Board meeting
Oct 2015
Sep 2015
Jul 2015
Apr 2015
Mar 2015
5 Mar · Board meeting
To consider the Business Plan of the Company for the Financial Year 2015-2016 amongst other items.
Jan 2015
6 Jan · Board meeting
To consider and approve the unaudited financial results for the quarter ended December 31st, 2014.
Oct 2014
7 Oct · Board meeting
To consider and approve the half-yearly audited financial results I quarterly limited review financial results for the period ended September 30, 2014. Further, as per the Company's Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will be closed for all directors/officers/designated employees of the Company from October 1, 2014 to October 31, 2014 (both days inclusive).
Aug 2014
1 Aug · Board meeting
Jul 2014
28 Jul · Board meeting